Exercise Effects on Cardiovascular Risk Factors, Quality of Life, Muscle Function in Type 2 Diabetes and Healthy Persons
NCT ID: NCT00852982
Last Updated: 2009-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
213 participants
INTERVENTIONAL
2006-04-30
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Nordic Walking and Exercise on Glucose Metabolism in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
NCT01085773
Effects of Different Types of Exercise in Type 2 Diabetes
NCT01182948
Exercise and Acarbose in Type 2 Diabetes
NCT01244971
Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
NCT06145542
Exercise Dose-Response Effects in Prediabetes
NCT00962962
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On inclusion and after four months the participants were therefore subject to clinical measurements, blood samples, maximal oxygen uptake tests on an ergometer cycle and muscle biopsies at inclusion and after four months of participation. They also answered an extensive questionnaire focusing on health related quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise
Five hours of Nordic walking per week, during four months
Exercise
Nordic walking, with walking poles, five hours per week during four months
Control
Control group asked not to alter lifestyle during study
Exercise
Nordic walking, with walking poles, five hours per week during four months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Nordic walking, with walking poles, five hours per week during four months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Symptomatic angina pectoris
* Insulin treatment
45 Years
69 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dep. of molecular medicine and surgery, Karolinska Institutet
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juleen Zierath, Professor
Role: PRINCIPAL_INVESTIGATOR
Dep. of molecular medicine and surgery, Karolinska Institutet
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Primary health care center
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Osler ME, Fritz T, Caidahl K, Krook A, Zierath JR, Wallberg-Henriksson H. Changes in gene expression in responders and nonresponders to a low-intensity walking intervention. Diabetes Care. 2015 Jun;38(6):1154-60. doi: 10.2337/dc14-2606. Epub 2015 Mar 20.
Fritz T, Caidahl K, Osler M, Ostenson CG, Zierath JR, Wandell P. Effects of Nordic walking on health-related quality of life in overweight individuals with type 2 diabetes mellitus, impaired or normal glucose tolerance. Diabet Med. 2011 Nov;28(11):1362-72. doi: 10.1111/j.1464-5491.2011.03348.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ALF 2006 03 25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.